173 related articles for article (PubMed ID: 38257173)
21. The use of urine peptidomics to define dietary gluten peptides from patients with celiac disease and the clinical relevance.
Monachesi C; Catassi G; Catassi C
Expert Rev Proteomics; 2023; 20(11):281-290. PubMed ID: 37855116
[TBL] [Abstract][Full Text] [Related]
22. Analysis of gluten immunogenic peptides in feces to assess adherence to the gluten-free diet in pediatric celiac patients.
Roca M; Donat E; Masip E; Crespo-Escobar P; Cañada-Martínez AJ; Polo B; Ribes-Koninckx C
Eur J Nutr; 2021 Jun; 60(4):2131-2140. PubMed ID: 33057793
[TBL] [Abstract][Full Text] [Related]
23. Prospective longitudinal study: use of faecal gluten immunogenic peptides to monitor children diagnosed with coeliac disease during transition to a gluten-free diet.
Comino I; Segura V; Ortigosa L; Espín B; Castillejo G; Garrote JA; Sierra C; Millán A; Ribes-Koninckx C; Román E; Rodríguez-Herrera A; Díaz J; Silvester JA; Cebolla Á; Sousa C
Aliment Pharmacol Ther; 2019 Jun; 49(12):1484-1492. PubMed ID: 31074004
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study.
Lähdeaho ML; Scheinin M; Vuotikka P; Taavela J; Popp A; Laukkarinen J; Koffert J; Koivurova OP; Pesu M; Kivelä L; Lovró Z; Keisala J; Isola J; Parnes JR; Leon F; Mäki M
Lancet Gastroenterol Hepatol; 2019 Dec; 4(12):948-959. PubMed ID: 31494096
[TBL] [Abstract][Full Text] [Related]
25. Symptoms of gluten ingestion in patients with non-celiac gluten sensitivity: A randomized clinical trial.
Moleski SM; Shah A; Durney P; Matthews M; Kaushal G; Smith C; Koons KC; Rubin E; Casey P; Miller R; Miller C; Jawairia M; Hasan A; DiMarino AJ
Nutrition; 2021 Jan; 81():110944. PubMed ID: 33053456
[TBL] [Abstract][Full Text] [Related]
26. Role of Serology, Dietary Assessment, and Fecal Gluten Immunogenic Peptides for Predicting Histologic Recovery in Children with Celiac Disease.
Seetharaman K; Lal SB; Prasad KK; Kumar Y; Bhatia A; Malhotra S
Dig Dis Sci; 2023 Feb; 68(2):529-540. PubMed ID: 36459294
[TBL] [Abstract][Full Text] [Related]
27. Dynamics and Considerations in the Determination of the Excretion of Gluten Immunogenic Peptides in Urine: Individual Variability at Low Gluten Intake.
Coto L; Sousa C; Cebolla A
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444783
[TBL] [Abstract][Full Text] [Related]
28. Fecal gluten immunogenic peptides as indicators of dietary compliance in celiac patients.
Porcelli B; Ferretti F; Cinci F; Biviano I; Santini A; Grande E; Quagliarella F; Terzuoli L; Bacarelli MR; Bizzaro N; Vascotto M; Marini M
Minerva Gastroenterol Dietol; 2020 Sep; 66(3):201-207. PubMed ID: 32218420
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the Usefulness of an Automatable Immunoassay for Monitoring Celiac Disease by Quantification of Immunogenic Gluten Peptides in Urine.
Segura V; Ruiz-Carnicer Á; Mendía I; Garzón-Benavides M; Pizarro ÁE; Comino I; Sousa C
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049570
[TBL] [Abstract][Full Text] [Related]
30. Non-Responsive and Refractory Coeliac Disease: Experience from the NHS England National Centre.
Penny HA; Rej A; Baggus EMR; Coleman SH; Ward R; Wild G; Bouma G; Trott N; Snowden JA; Wright J; Cross SS; Hadjivassiliou M; Sanders DS
Nutrients; 2022 Jul; 14(13):. PubMed ID: 35807956
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study.
Tye-Din JA; Daveson AJM; Goel G; Goldstein KE; Hand HL; Neff KM; Popp A; Taavela J; Maki M; Isola J; Williams LJ; Truitt KE; Anderson RP;
Lancet Gastroenterol Hepatol; 2023 May; 8(5):446-457. PubMed ID: 36898393
[TBL] [Abstract][Full Text] [Related]
32. Monitoring coeliac disease in 2024, time to change practice?
Raju SA; Shiha MG; Penny HA
Curr Opin Gastroenterol; 2024 May; 40(3):190-195. PubMed ID: 38547329
[TBL] [Abstract][Full Text] [Related]
33. Diet adherence and gluten exposure in coeliac disease and self-reported non-coeliac gluten sensitivity.
Løvik A; Skodje G; Bratlie J; Brottveit M; Lundin KE
Clin Nutr; 2017 Feb; 36(1):275-280. PubMed ID: 26714791
[TBL] [Abstract][Full Text] [Related]
34. Double-Blind Randomized Clinical Trial: Gluten versus Placebo Rechallenge in Patients with Lymphocytic Enteritis and Suspected Celiac Disease.
Rosinach M; Fernández-Bañares F; Carrasco A; Ibarra M; Temiño R; Salas A; Esteve M
PLoS One; 2016; 11(7):e0157879. PubMed ID: 27392045
[TBL] [Abstract][Full Text] [Related]
35. Coeliac disease and gastrointestinal symptom screening in adult first-degree relatives.
Vaquero L; Rodríguez-Martín L; Alvarez-Cuenllas B; Hernando M; Iglesias-Blazquez C; Menéndez-Arias C; Vivas S
J Gastroenterol Hepatol; 2017 Dec; 32(12):1931-1937. PubMed ID: 28387454
[TBL] [Abstract][Full Text] [Related]
36. Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study.
Kelly CP; Green PH; Murray JA; Dimarino A; Colatrella A; Leffler DA; Alexander T; Arsenescu R; Leon F; Jiang JG; Arterburn LA; Paterson BM; Fedorak RN;
Aliment Pharmacol Ther; 2013 Jan; 37(2):252-62. PubMed ID: 23163616
[TBL] [Abstract][Full Text] [Related]
37. Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease.
Daveson AJM; Tye-Din JA; Goel G; Goldstein KE; Hand HL; Neff KM; Williams LJ; Truitt KE; Anderson RP;
Aliment Pharmacol Ther; 2020 Jan; 51(2):244-252. PubMed ID: 31769533
[TBL] [Abstract][Full Text] [Related]
38. A Sensitive Whole Blood Assay Detects Antigen-Stimulated Cytokine Release From CD4+ T Cells and Facilitates Immunomonitoring in a Phase 2 Clinical Trial of Nexvax2 in Coeliac Disease.
Hardy MY; Goel G; Russell AK; Chen Yi Mei SLG; Brown GJE; Wang S; Szymczak E; Zhang R; Goldstein KE; Neff KM; Williams LJ; Truitt KE; Dzuris JL; Tye-Din JA; Anderson RP
Front Immunol; 2021; 12():661622. PubMed ID: 34093551
[TBL] [Abstract][Full Text] [Related]
39. Non-coeliac gluten or wheat sensitivity: emerging disease or misdiagnosis?
Potter M; Walker MM; Talley NJ
Med J Aust; 2017 Aug; 207(5):211-215. PubMed ID: 28987135
[TBL] [Abstract][Full Text] [Related]
40. Symptomatic suspected gluten exposure is common among patients with coeliac disease on a gluten-free diet.
Silvester JA; Graff LA; Rigaux L; Walker JR; Duerksen DR
Aliment Pharmacol Ther; 2016 Sep; 44(6):612-9. PubMed ID: 27443825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
